PHA Classroom banner

PHA Classroom has moved! Visit

>> Back to Recordings

Session Recording from PHA's 2010 9th International PH Conference

Thromboembolic Disease and PAH: The Spectrum of Therapies

June 27, 2010 

Thromboembolic Disease and PAH: The Spectrum of Therapies panelistsChronic Thromboembolic Pulmonary Hypertension (CTEPH) is a progressive disease that can result in severe shortness of breath and disability. It also appears to be more common than previously realized. Unlike most other causes of pulmonary hypertension, CTEPH is often cured with surgery (pulmonary endarterectomy); although very few centers perform this procedure. We will discuss the diagnosis and medicinal and surgical treatment of CTEPH with a particular focus on treatment and outcomes.

View Session Recording
(recording will open in a new window)

Presenter Information

Nick H. Kim, MD, University of California, San Diego, La Jolla, Calif. (Chair)
Richard Channick, MD, Massachusetts General Hospital, Boston, Mass.
Victor Test, MD, University of California, San Diego, La Jolla, Calif.





Actelion Pharmaceuticals US, Inc. Gilead Sciences, Inc. Bayer HealthCare United Therapeutics Corporation
This is a program of the PHA Medical Education Fund, made possible through unrestricted educational grants from our supporters.


FacebookTwitterInstagram iconLinkedInYouTube

For optimal viewing of, please use a standards-compliant browser such as Google Chrome or Firefox.

The information provided on the PHA website is provided for general information only. It is not intended as legal, medical or other professional advice, and should not be relied upon as a substitute for consultations with qualified professionals who are familiar with your individual needs.

801 Roeder Road, Ste. 1000, Silver Spring, MD 20910   Patient-to-Patient Support Line: 1-800-748-7274
    Privacy Policy    Provide Feedback & Report Bugs

Designed by Matrix Group International, Inc.® | © 2016 Pulmonary Hypertension Association. All Rights Reserved.


The National Organization for Rare Disorders (NORD) awarded PHA the Abbey S. Meyers Leadership Award in 2012 for outstanding service to PHA members in advocacy, education and other key areas.